Isomorphic Labs in Talks for 5 Billion Dollars at 50 Billion Dollar Valuation, Bloomberg Reports www.trendingtopics.eu Demis Hassabis is raising more money for a company without a single drug tested in humans than most pharma giants spend on research in…
On November 4, Gustaf Arlid bought 2,250 shares in e-commerce company Rugvista, where he is CFO. The shares were purchased at SEK 78.85 per share, for a total transaction value of SEK 177,400. The... Rugvista's newly appointed CFO Gustaf Arlid makes his first stock…
apollon.bio announced that it has raised KRW 5 billion in a round of funding led by new investor SBI Investment Korea Co., Ltd. on September 23, 2026. The transaction included participation from new... SBI Investment KOREA Co., Ltd. Investment Management & Fund Operators…
Kalkine Media On November 4, 2026, Christopher R. Fenimore, EVP Finance and CFO of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) REGN (NASDAQ:REGN), submitted a Form 4 revealing multiple transactions involving Regeneron common stock dated November 2, 2026. On November 2, 2026, Fenimore also disposed of 4,243 shares at $950.50 each…
TradingView UVV: Weak H1 results; tobacco shipments and results are expected to skew to H2 Q2 and YTD revenue, operating income, net income, and diluted EPS were below 2025 levels. Tobacco results are expected to be H2-weighted, supported by customer commitments and target-range uncommitted…
Nov 5 (Reuters) – Indian drugmaker Dr Reddy’s Laboratories said on Thursday it had received regulatory approval in Brazil to market and sell a generic version of Novo Nordisk’s blockbuster diabetes drug Ozempic. • Brazil has 16.6 million adults aged between 20 and 79 living with…
Board declared a quarterly cash dividend of $0.36 per share, payable Dec 31, 2026 to holders of record Dec 15; director Lund retiring in… Plus members following SCI get this by push and email at 15:19:22 ET - it reached us 28 seconds after publication. Written by…
lincolnjournal.com Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Sorry, an error occurred. Account processing issue - the email address may already exist Must be at least 8 characters, not…
TradingView Accuray Incorporated (ARAY) Approves 1-for-40 Reverse Split to Address Nasdaq Listing Compliance Accuray approved a 1-for-40 reverse split, effective November 9, 2026. Outstanding shares will decrease from approximately 120.2M to approximately 3.0M; the split aims to help regain Nasdaq minimum-bid-price compliance. Context by…
Jindalee Lithium (ASX:JLL) is targeting a Nasdaq listing for its McDermitt Lithium Project in Oregon, US, during the December quarter after its US registration statement took effect. The US Securities and Exchange Commission (SEC) declared effective the Form S-4 filed…
Biotechnology, gene editing, biopharma platforms, and clinical pipelines.
An article joins this feed when it matches these terms. Each one is also a search of its own.